Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis

Clinical Journal of Gastroenterology

Volumn 5, Issue 2, 2012, Pages 141-145

  Oeda, Satoshi ^a   Mizuta, Toshihiko ^a   Isoda, Hiroshi ^a   Kuwashiro, Takuya ^a   Oza, Noriko ^a   Iwane, Shinji ^a   Takahashi, Hirokazu ^a   Kawaguchi, Yasunori ^a   Eguchi, Yuichiro ^a   Toda, Shuji ^a   Ozaki, Iwata ^a   Anzai, Keizo ^a   Fujimoto, Kazuma ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Autoimmune hepatitis; Chronic hepatitis C; Corticosteroid; Interferon; Ribavirin

Indexed keywords

PEGINTERFERON ALPHA2B; PILOCARPINE; PREDNISOLONE; RIBAVIRIN;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER FUNCTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84863720411     PISSN: 18657257     EISSN: 18657265     Source Type: Journal    
DOI: 10.1007/s12328-012-0295-4     Document Type: Article

References (17)

1. Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010; 9:191-206.
2. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, et al. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol. 1997;26:1207-12.
3. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. QJ Med. 1971; 40:159-85.
4. Soloway RD, Summerskill WH, Baggenstoss AH, Geall MG, Gitnićk GL, Elveback IR, et al. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology. 1972;63:820-33.
5. Murray-Lyon IM, Stern RB, Williams R. Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet. 1973;1:735-7.
6. Shindo M, Di Bisceglie AM, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology. 1992;102:1406-8.
7. Kogure T, Ueno Y, Fukushima K, Nagasaki F, Inoue J, Kakazu E, et al. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol. 2007;13:4394-7.
8. Coriat R, Podevin P. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient. Int J STD AIDS. 2008;19:208-10.
9. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929-38.
10. Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology. 2008;48:169-76.
11. Bai L, Lu HY, Feng ZR, Yu M, Li WG, Gong WB, et al. Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal type 1 antibodies (anti-LKM1) in patients with chronic hepatitis C. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009;23:278-81.
12. Nishioka M, Morshed SA, Kono K, Himoto T, Parveen S, Arima K, et al. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol. 1997;26:992-1000.
13. Carpenter HA, Czaja AJ. The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants. Clin Liver Dis. 2002;6:685-705.
14. Schiano TD, Te HS, Thomas RM, Hussain H, Bond K, Black M. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol. 2001;96:2984-91.
15. Ballary S, Schiano T, Hartman G, Black M. Chronic hepatitis with combined features on autoimmune chronic hepatitis and chronic hepatitis C: favorable response to predonisone and azathioprine. Ann Intern Med. 1995;123:32-4.
16. Magrin S, Craxi A, Fabiano C, Fiorentino G, Almasio P, Palazzo U, et al. Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol. 1991;13:364-7.
17. Petersen-Benz C, Kasper HU, Dries V, Goeser T. Differential efficacy of corticosteroids and interferon in a patient with chronic hepatitis C-autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2004;2:440-3.